Search

The capacity for nanopatterning and functionality is a promising facet of supramolecular self‐assembly. However, the formation of molecular frameworks entirely dependent on van der Waals (vdW) interactions is infrequently explored. Herein, 2D vdW supramolecular structures are synthesized through the self‐assembled cocrystallization of C60 and decanethiol (DT) molecules on Au(111) surface. Notably, the system eliminates the need of functional groups for specific bonding between adjacent units. The conformation C60/DT is delicately manipulated by adjusting molecular coverage and annealing temperature. The absence of directional bonding between C60 and DT molecules facilitates the formation of a variety of stable phases at room temperature (RT), such as 1) porous C60 networks with thiol‐filled pores and 2) self‐synthesized (C60)n nanochains with thiol spacers interspersed between the chains are achieved and visualized by scanning tunneling microscopic imaging under RT. This innovative integration of the vdW interaction unveils new avenues for developing supramolecular patterns characterized by their comparatively weak but exceptionally adaptable bonding. [ABSTRACT FROM AUTHOR]

Knowledge of protein–ligand interactions is beneficial for biological process analysis and drug design. Given the complexity of the interactions and the inadequacy of experimental data, accurate ligand binding residue and pocket prediction remains challenging. In this study, we introduce an easy‐to‐use web server BindWeb for ligand‐specific and ligand‐general binding residue and pocket prediction from protein structures. BindWeb integrates a graph neural network GraphBind with a hybrid convolutional neural network and bidirectional long short‐term memory network DELIA to identify binding residues. Furthermore, BindWeb clusters the predicted binding residues to binding pockets with mean shift clustering. The experimental results and case study demonstrate that BindWeb benefits from the complementarity of two base methods. BindWeb is freely available for academic use at http://www.csbio.sjtu.edu.cn/bioinf/BindWeb/. [ABSTRACT FROM AUTHOR]

Background: Acquired resistance of chemotherapy, especially cisplatin, is a major challenge in lung cancer treatment. We conducted this study to examine whether a cyclin D kinase 4/6 (CDK4/6) inhibitor, PD 0332991, could reverse cisplatin resistance in human lung cancer cells. In addition, we explored the underlying mechanisms. Method: We used CCK‐8 assay to got the IC50 of PD‐0332991 and cisplatin in A549 and A549/CDDP respectively. CCK‐8 assay, CalcuSyn 2.0 software, cell cycle distribution and apoptosis used to identify PD‐0332991 could reverse the acquired resistance of cisplatin. At last, western‐blot used to show the mechanism of PD‐0332991 enhances the effects of cisplatin. Results: We found that PD‐0332991 potentiated cisplatin‐induced growth inhibition in both cisplatin‐sensitive (A549) and cisplatin‐resistant (A549/CDDP) cells via downregulation of the proliferation, induction of apoptosis (A549 increased to 7.06%; A549/CDDP increased to 7.03%), and G0/G1 cell cycle arrest (A549 increased to 9.15%; A549/CDDP increased to 49.92%). Western blot analysis revealed that PD‐0332991 enhance the effect of cisplatin through inhibit Rb‐E2Fs pathway. Conclusions: These findings suggest that PD‐0332991 could reverse the acquired resistance of cisplatin in lung cancer cells and provide a novel treatment strategy for lung cancer patients with cisplatin resistance. [ABSTRACT FROM AUTHOR]

Background: The purpose of this study was to validate stage groupings in the 8th edition of the tumor node metastasis (TNM) classification for lung adenocarcinoma and explore the non‐anatomic factors that influence the prognosis of lung adenocarcinoma patients in China. Methods: We retrospectively analyzed the data of 291 lung adenocarcinoma patients at our department between 2008 and 2013. Logrank tests and Cox regression models were used to analyze survival among adjacent stage groupings. Kaplan–Meier curves were used to estimate overall survival (OS). Results: There were significant differences in OS in adjacent stage groupings in early stages in the 8th edition. There were also significant differences between patients treated with radical surgery and limited resection (P = 0.027). Lepidic predominant adenocarcinoma (LPA) had better survival rates than acinar predominant (APA), papillary predominant, and solid predominant with mucin production adenocarcinoma (SPA) (P = 0.008). Survival rates of micropapillary predominant adenocarcinoma were lower than the others (P = 0.003). EGFR mutations were closely associated with lepidic predominant (65%, P = 0.56) but less commonly associated with solid predominant with mucin production adenocarcinoma (24%, P = 0.02). There was no significant difference in survival between EGFR gene mutation‐positive and negative groups (P = 0.402). Conclusion: The 8th edition TNM may be more accurate and applicable than the 7th edition for Chinese lung adenocarcinoma patients who have undergone surgical treatment. Stage IV patients may gain survival improvement from radical surgery. [ABSTRACT FROM AUTHOR]